CoEBoC 2018-2025
Together with five other research groups we form a Centre of Excellence in Body-on-Chip Research, CoEBoC. Funded by Academy of Finland, the multidisciplinary research consortium develops a new “Body-on-Chip” platform for modelling the function of human tissues and diseased states. The platform consists of several cultured vascularised and innervated tissue blocks. Our role is to develop microfluidic chips and sensors to be used in the CoEBoC’s applications.
SUSBIO 2023-2028
Sustainable Biomedical and Toxicological Research (SUSBIO) is one of the profiling areas at Tampere University. It aims to develop novel sustainable soft materials and advanced in vitro methods for studying human physiology and simulating complex disease mechanisms. We are a part of the action.
BF MEMO 2022-2024
Modular platform for modelling epilepsy in vitro, MEMO, develops a microfluidic in vitro model for epilepsy. Technology first develop in a project funded by the Academy of Finland and now the commercialization potential is investigated in a “from research to business” project funded by Business Finland.
ASEMO 2022-2026
ASEMO, funded by the Research Council of Finland, develops novel technologies to study epilepsy, Our tasks include the development of compartmentalized oxygen control, measurement and perfusion to enable sophisticated studies on epileptic seizures using human induced pluripotent stem cell based neuronal models.
PRIME 2021-2024
We are part of the EU FET project “Personalised Living Cell Synthetic Computing Circuit for Sensing and Treating Neurodegenerative Disorders (PRIME)” coordinated by South East Technological University in Ireland. The goal of the project is to provide a transformational diagnostic-therapeutic treatment for epilepsy and other neurological diseases.
SMELLODI 2022-2025
EU Pathfinder project “Smart Electronic Olfaction for Body Odor Diagnostics (SMELLODI)” coordinated by Dresden University of Technology in Germany. The project aims to develop intelligent electronic sensors that can detect and digitally transmit healthy and pathologically altered body odours.